Page not found

Search results

  1. Jeff Conn named 2021 fellow of American Society for Pharmacology and Experimental Therapeutics

    ... fundamental breakthroughs in neuroscience to develop new treatments for brain disorders. The main research in his laboratory works ...

    sommers - 10/07/2021 - 8:29am

  2. Two Vanderbilt biomedical engineers lead top academic societies in their fields

    ... drawn to building consensus, and I am not afraid to explore new ideas to arrive at a better outcome,” Reinhart-King said. “We also are ...

    sommers - 09/27/2021 - 3:28pm

  3. VUMC joins international effort to speed vaccine development

    ... is being tested as a potential treatment for Ebola. The new consortium will focus on clinical development of therapeutic candidates for ...  Jr., PhD, at Tulane University School of Medicine in New Orleans, will guide clinical development of first-in-class human ...

    sommers - 06/07/2019 - 9:28am

  4. La Jolla Pharmaceutical Company and Vanderbilt University Enter Exclusive Research and License Agreement Covering Novel BMP Type-I Receptor Inhibitors

    08/18/2015 A new research alliance between Dr. Charles Hong, associate Professor of ... relating to: the timing for the filing of an Investigational New Drug Application, commencement of clinical studies and the anticipated ...

    steelmk - 10/02/2015 - 10:45am

  5. Vanderbilt 14th among nation’s top universities in latest ‘U.S. News’ rankings

    ... of inclusion and belonging that will allow us to usher in a new era of collective achievement at Vanderbilt.” The 2022 Best Colleges ...

    sommers - 09/15/2021 - 3:15pm

  6. CTTC breaks records in rapid facilitation of COVID-19 related agreements

    ... is to allow the development of purposeful products from new inventions. A license agreement is a contract that enables an entity to ... time of the AstraZeneca agreement – 10 days – is a new speed record for a therapeutic license agreement,” said Bentley. “The ...

    sommers - 07/10/2020 - 8:21am

  7. VUMC Licensee Evotec Starts Clinical Development of Chikungunya Antibody

    ... outbreaks. In recent years, chikungunya virus reached new areas including non-tropical regions. There are currently no effective ...

    sommers - 01/29/2021 - 8:45am

  8. Vanderbilt receives $20 million from The William K. Warren Foundation to further treatments for brain disorders

    ... working to translate essential research ideas into viable new drug treatments that prevent serious brain disorders, like Alzheimer’s, ...

    sommers - 05/06/2020 - 12:38pm

  9. Dolly Parton Makes Generous Gift to Advance COVID-19 Research at Vanderbilt

    ... In addition, investigators are focusing on entirely new therapies that could effectively treat and prevent the infection. Both ...

    sommers - 04/07/2020 - 10:42am

  10. VUMC team aids development of potential antiviral drug for COVID-19

    ... are playing a key role in the development of a potential new antiviral drug to treat COVID-19. The drug, named EIDD-1931, was ...

    sommers - 04/07/2020 - 10:28am